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Abstract
Background: Relapse of tuberculosis (TB) may develop as the result of reactivation of the endogenous primary infection, or
as a result of a exogenous reinfection. This survey evaluated the rate of reactivation versus recent transmission among Iranian
and Afghan relapse cases.
Methods: The sputum specimens were digested, examined microscopically for acid-fast bacilli, and inoculated into Löwenstein-
Jensen slants by standard procedures. Thereafter, the susceptibility and identification tests were performed on culture positive
specimens. Subsequently, the strains that were identified as Mycobacterium tuberculosis (258 isolates) were subjected to IS6110
restriction fragment length polymorphism (RFLP) and spoligotyping. Additional patient's information was collected for further
epidemiological analysis. Patients whose isolates had identical genotyping patterns were considered a cluster with recent
transmission episode.
Results: Out of 258 available isolates, 72(28%) had multi-drug resistant (MDR-TB) in ratio and 42 (16.2%) had other resistant.
Notably, 38 of MDR-TB cases (52%) were isolated from Afghan patients. By IS6110-RFLP typing method, 65 patients (25%) were
clustered in 29 clusters. In cluster cases, the intra-community transmissions between Iranian and Afghan patients were 41%. All
MDR-TB patients in clusters had either Haarlem I or Beijing characteristic. The risk factors like sex, family history, close contact,
living condition, PPD test result and site of TB infection were not associated with clustering. Although, the MDR-TB strains were
more frequent in non-cluster cases (31%) than cluster one(18%) (P < 0.05). Majority of M. tuberculosis strains isolated from non-
cluster cases were belong to EAI3 (51; 30%) and CASI(32;18.6%) superfamilies.
Conclusion: During the studied period, reactivation of a previous infection remain the more probable cause of recurrence.
Although, the evidence of intra- community transmission between Iranian and Afghan TB cases, highlighted the impact of afghan
immigrants in national tuberculosis control program (NTP) of Iran.
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Background
Restriction fragment length polymorphism (RFLP) using
insertion sequence IS6110 is a well-established method of
"DNA fingerprinting" that has been used to trace the
transmission of particular strains of M. tuberculosis isolates
[1,2]. The method is based on the detection of differences
in the numbers and locations of the insertion element
IS6110 within the chromosomes of M. tuberculosis strains
[2,3]. Generally, the unrelated clinical isolates show a
high degree of variation, whereas, epidemiologically
related strains show identical or similar fingerprint pat-
terns [4,5]. By IS6110-RFLP, it was also possible to deter-
mine whether a new episode of disease is caused by
reactivation of endogenous infection or by exogenous
reinfection [6,7]. The exogenous reinfection can either
occur during therapy for the original infection or after
therapy has been completed [8]. In overall, the frequency
with which the patient reinfected with M. tuberculosis are
reported to be variable. In South Africa, the frequency of
exogenous reinfection reported to be high, whereas in
other places it has been involved selected populations
e.g., alcoholic residents of a homeless shelter or patients
with advanced HIV infection[8,9]. In Iran, the extent in
which exogenous reinfection contributed to incidence of
the diseases are not known. According to the World
Health Organization, the estimated incidence of TB in
Iran is 28 cases per 100000 populations [10]. The TB
problem has become more serve because of an increase in
MDR-TB strains. Based on national wide survey con-
ducted in 1999, among all M. tuberculosis isolates tested
for drug susceptibility, 10.9% were resistant to ≥ 1 anti-TB
drug, and 6.7% were resistant to both isoniazid and
rifampin (i.e., were MDR strains of M. tuberculosis)[11]. In
further studies, the existence and transmission of XDR-TB
strains (i.e., resistant to fluoroquinolones and to at least
one of the three inject able second line drugs in addition
to isoniazid and rifampin) in epidemiological related
MDR-TB patients were demonstrated [12]. Considering
the severity of diseases associated with spread and trans-
mission of MDR or XDR-TB strains, we tried to determine
the relative frequency of reactivation from recent trans-
mission among relapse cases using IS6110-RFLP. How-
ever, since RFLP analysis with IS6110 alone may be
inconclusive for strains carrying few copies of IS6110 [13],
we also used an alternative PCR-technique called spoligo-
typing. The technique detects various non-repetitive
spacer sequences located between small repetitive units
(direct repeat DR) in the chromosome on M. tuberculosis
complex [14]. In present study, the contribution of
Afghan immigrants in maintaining the recurrent tubercu-
losis was also determined.
Methods
Setting
The National Research Institute of tuberculosis and Lung
Diseases (Tehran/Iran), which acts as the reference unit
for National Tuberculosis Program, is the only centre for
diagnosis and treatment of MDR and relapse TB patients.
Patients
Patients included in this study had at least two episodes of
TB, with cure as the outcome of the first episode. Accord-
ing to WHO criteria, cure was defined as the completion
of a course of six to eight months of directly observed
combination therapy (with isoniazid, rifampin, and
pyrazinamide in a single tablet), compliance (attendance
for the course of therapy, with at least 80 percent of pre-
scribed doses taken), and a sputum culture positive for M.
tuberculosis at diagnosis and at least one negative sputum
culture at the end of treatment. Recurrence or relapse was
defined as development of a culture positive for M. tuber-
culosis and symptoms consistent with tuberculosis after
the patient had completed a course of treatment and had
been confirmed culture negative and clinically recovered
[11].
Data collection
The study was conducted from June 2006 to June 2007.
Generally, all heath facilities in Tehran refer their TB sus-
pect to National Reference TB laboratory (NRL) Tehran,
Iran for susceptibility and identification test. Case data
were collected by trained technicians using standard ques-
tionnaires. Information was obtained on sex (female &
male), age, contact (family contact/close contact), previ-
ous TB history, present address and associated medical
data such as HIV infection (yes, no, not known), and
tuberculin skin test (+, -, equivocal). The patients with
similar or highly similar IS6110-RFLP fingerprint patterns
were interviewed together. The Institutional Review Board
at the National Research Institute of Tuberculosis and
Lung Diseases in Tehran approved the study.
Bacterial strains
Primary isolation and culturing of Mycobacterium isolates
from sputum specimen were followed in accordance to
procedures manual [15]. All isolates were identified as M.
tuberculosis by using biochemical tests, including produc-
tion of niacin, catalase activity, nitrate reduction, pigment
production and growth rate [15]. Drug susceptibility test-
ing against isoniazid (INH), rifampicin (RF), streptomy-
cin (SM), ethambutol (ETB) and pyrazinamide (PZA)
were performed by the proportional method on Löwen-
stein-Jensen media at a concentration of 0.2,40,4.0 and
2.0 μg/ml, respectively [16].BMC Infectious Diseases 2008, 8:109 http://www.biomedcentral.com/1471-2334/8/109
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IS6110-RFLP typing
DNA extraction, digestion and southern blotting were per-
formed by standard protocols[1,2]. 5–10 ng of chromo-
somal DNA was digested with 2 unit/μl of PVUII
restriction enzyme and was hybridized with a 10 μl of
probe which prepared from a 245 bp PCR product of
IS6110.
Spoligotyping
The method was performed as previously described by
Kamerbeek et al [17]. In brief, DR region was amplified by
PCR using primers derived from the DR sequence. The
amplified DNA was hybridized to a set of 43 immobilized
oligonucleotides derived from the spacer sequences of M.
tuberculosis H37RV and M. Bovis BCG P3 by reverse line
blotting.
Computer-assisted analysis of fingerprints
The autoradiograph of IS6110-RFLP and spoligotyping
were scanned with Snap Scan 1236 Scanner. Bionumerics
Software (version 2.5, Applied Math's) was used to ana-
lyze the molecular patterns generated by IS6110-RFLP and
spoligotyping. The dendograms were generated by the
hierarchic unweighted pair group method analysis
(UPGMA) clustering algorithm. (The UPGMA used
because the distance between two clusters was calculated
as the average distance between all pairs of objects in two
different clusters). Strains were classified in a cluster when
they shared similar IS6110-RFLP and spoligotyping pat-
terns.
Statistical analysis
The continuous variables were expressed as group means
± SD. The Variables were included sex, age, Family/close
contact, pattern of drug resistance, PPD test, between the
groups of tuberculosis patients in cluster (consider as a
recent transmission) and non-cluster cases (consider as a
reactivation).
Results
Particulars of the Patients
The study involved 199; 77.1% Iranian and 59; 22.8%
afghan cases. The median age was 47 and 38 years for Ira-
nian and Afghan TB patients, respectively (table. 1).
111(43%) were female and 147(56.9%) were male. The
male to female ratio was 1.3:1. As shown in table. 1, 131
Iranian (65%) and 13 Afghan cases (22%) were suscepti-
ble to all 4 drug tested. The results showed that 72 patients
(28%) were MDR-TB cases. Notably, 38 MDR-TB cases
(52.7%) were isolated from afghan immigrants. Twenty
patients (47%) had mono drug resistant strains (nine
were INH, seven SM, three RF and one ETB monoresist-
ant) and 22 (52%) had combined resistance. 62 patients
(24%) had family history or were in contact with TB
patients. HIV infection status was available for 98 patients
(37%); out of which two were HIV positive (2.0%).
Reviewing the patients questionnaires revealed that the
crowded, poor-living condition (233; 93%), and low-sal-
ary (220; 85%) were common factors increasing the risk
of developing TB (table. 1).
Table 1: Detail demographic data of the studied population.
Non-cluster Patients (193 = 74.8%) Cluster patients (65; 25%)
Nationality Iranian 151(78.2%) Afghani 42(21.3%) Iranian 48(73%) Afghani 17(26%)
Mean age 47.91 ± 25 39.65 ± 11 44.17 ± 19 36.19 ± 8
Female 70(46.3%) 15(35.7%) 18(37.5%) 8(47%)
Male 81(53.6%) 27(64.2%) 30(62.5%) 9(56.9%)
Pulmonary 147 (97.3%) 37(88%) 47(97.9.%) 14(46.4%)
Extra-pulmonary 2(1.3%) 3(7.1%) 0 2 (30.7%)
Both 2 (1.3%) 2(4.7%) 1(2.0%) 1(1.5%)
AIDS 2(1.3%)Positive 17 (40.4%) Negative 3(6.25) Negative 17(26.1%) NA
76(97.5%) Negative 25(59.5%)NA 41(85.4%) NA
73(48.3%) NA
PPD 72(47%) Positive 16(38%) Positive 19(39.5%) Positive 4(23%) Positive
18 (11.9%) Negative 5 (11.9%) Negative 8 (16.6%) Negative 3 (7.6%) Negative
25(16.5%)equivocal 9(21.9%)equivocole 14 (29.1%)equivocole 7(11%) equivocole
36(23.8%) NA* 12(28.5%) NA 7(14.5%) NA 5(29.4%) NA
History of family or close contact 27(17.8%) 17(40%) 10 (20.8%) 8(47.9%)
96(63.5%) 5(11.9%) 35 (72.9%) 8(33%)
Susceptible 29(19.2%) 31 (73.8%) 5(10.4%) 7(41.1%)
MDR-Other resistant 26(17.2%) 6(14.2%) 8 (16.6%) 2(11.7%)
Crowded and low living condition 134(88.7%) 38 (90%) 44 (91.6%) 17(100%)
Low-Salary 129(85.4%) 40(95.2%) 35(72.9%) 16(94.1%)
*.NA, the data were not availableBMC Infectious Diseases 2008, 8:109 http://www.biomedcentral.com/1471-2334/8/109
Page 4 of 7
(page number not for citation purposes)
IS6110-copy number
The copy number of IS6110 in each of the isolates was
determined from the number of bands hybridizing the
probes. Average number of IS6110  copies was 10.82
among Iranian and 11.8 among Afghan cases. The differ-
ences was not statistically significant (P > 0.05). Twenty
one isolates (8.1%) contain 1–4 copies of IS6110 (Low-
copy number), 218 isolates (88.3%) contain 6–15 copies
and 31 isolates (12%) had more than 16 copies (high-
copy number). Ten isolates (3.8%) had no copies of
IS6110.
Diversity of RFLP
In this study, 193 strains (74.8%) were infected with
genetically different M. tuberculosis strains based on
IS6110-RFLP pattern. 65 patients (25%) were clustered in
29 clusters. The size of clusters were ranging from 2 to 3
isolates, 22 clusters had 2 isolates (75.8%) and 6 clusters
had 3 isolates (20.3%).
Spoligopatterns
Thirty-six distinct spoligopatterns were observed. In total,
27 orphan patterns (10.4%) were seen and the remaining
231(89%) were contained within 9 superfamilies;
EAI3(58; 25%), CASI(41; 17.7%), EAI4(32; 13.8%),
T1(31; 13.4%), T2(16; 6.9%), HaarlemI (20; 8.6%),
X1(12; 5%), Beijing(12; 5%) and CASII(9; 3.8%).
Although, the diversity of these super families were differ-
ent in cluster and non-cluster cases. As shown in table 2,
the major superfamilies among non-cluster cases were
EAI3 (30%), and CASI (18.6%), whereas in cluster cases
were Haarlem I (27.6%), and Beijing (17%). The overall
diversity of observed cluster was 0.13 (diversity = the
number of shared types divided by total number of found
isolates i.e., 36/258 = 0.13).
Epidemiological studies of patients in clusters
65 M. tuberculosis isolates were clustered in 29 clusters.
Sixteen clusters (55%) contained 34 Iranian TB cases and
one cluster (3.4%) had two Afghan patients. The remain-
ing clusters (12; 41%), were contained both native and
Afghan TB cases (Figure. 1). Afghan patients in the clusters
were immigrated in the last 10–15 years and all of them
had one incomplete course of treatment in Afghanistan
and one episode of TB in Iran. The mean of age in Iranian
cases was 44.17 ± 19 (SD), whereas in Afghan cases was
36.19 ± 8 (SD) (P < 0.05). Reviewing the patient's ques-
tionnaires revealed that only 18 individuals (27.6%) had
a family history or was in contact with TB patients (P >
0.05). Statistical analysis showed that patients in clusters
were more likely to be male than female (1.6:1). The sus-
ceptibility results showed that 12 patients were MDR-TB
cases, in which 7(58.3%) belong to afghan immigrants. A
retrospective analysis found no direct transmission link
between patients in clusters. Although, these patients
developed their second episode of TB in the same period.
It was also important to notice that all MDR-TB cases in
clusters were belonged to Haarlem I and Beijing type of
strains.
Discussion
Using molecular typing, twenty-five percent of relapse
cases (65; 25%) were clustered in 29 clusters. A retrospec-
tive studies revealed that patients in clusters developed
their second episode of TB within the same period. Fur-
ther analysis of spoligopatterns identified Haarlem I and
Beijing types of M. tuberculosis strains in thirty eight per-
cent of patients in clusters(38%)(table. 2). Therefore, the
possibility of exogenous reinfection through transmission
of particular M. tuberculosis strains were highlighted.
Although, due to non-availability of previous culture gen-
otyping results, we could not confirm the exogenous rein-
Table 2: The spoligopatterns in cluster and non cluster cases
Spoligopatterns Non-cluster cases (n = 193) Cluster cases (n = 65)
Iranian (n = 151) Afghanis (n = 42) Iranian (n = 48) Afghanis (n = 17) Total
EAI3 39(30.4%) 12(3.5%) 4(8.3%) 3(17.6%) 58(25.4%)
CASI 19(14.5%) 12(3.5%) 10(20.8%) 0(0%) 41(17.7%)
EAI4 26(20.3%) 3(7.8%) 2(4.1%) 1(5.8%) 32(13.8%)
T1 26(20.3%) 2(5.2%) 3(6.2%) 0(0%) 31(13.4%)
T2 8(6.25%) 0(0%) 7(14.5%) 1(5.8%) 16(6.9%)
Haarlem I 2(1.5%) 0(0%) 12(25%) 6(35.2%) 20(8.6%)
Beijing 1(0.78%) 0(0%) 7(14.5%) 4(23%) 12(5.1%)
X1 0(0%) 9(23.6%) 1(2.0%) 2(11.7%) 12(5.1%)
CASII 7(5.4%) 0(0%) 2(4.1%) 0(0%) 9(3.8%)
Total 128 38 48 17 231
Orphan cases 23(85.1%) 4(14.8%) 0(0%) 0(0%) 27BMC Infectious Diseases 2008, 8:109 http://www.biomedcentral.com/1471-2334/8/109
Page 5 of 7
(page number not for citation purposes)
The figure show the intra-community transmission among Iranian and Afghan relapse cases Figure 1
The figure show the intra-community transmission among Iranian and Afghan relapse cases.
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fection in them. Recently, investigators have suggested
that the relative contribution of exogenous reinfection
increases in parallel with the incidence of disease [6,8,18].
Most reported cases of exogenous reinfection observed
among alcoholic residents of a homeless shelter or
patients with advanced HIV infection [6,9,19]. We found
no particular risk factors between patients in cluster and
non-cluster cases. Retrospective analysis of cluster cases
identified 41% of intra- community transmission
between Iranian and Afghan TB patients. In our previous
study, the impact of intra- community transmission was
much lower (13.7%) than present result. Furthermore, we
found that the Haarlem I and Beijing type of M. tuberculo-
sis strains were the most frequent super families in intra-
community transmission (figure. 1). The Haarlem I and
Beijing strains have been reported in different geographi-
cal regions of the world and they thought to possess selec-
tive advantages in comparison to other M. tuberculosis
super families [22,23]. Previously, we demonstrated that
44% of MDR-TB patients in intra-community transmis-
sion were belonged to HaarlemI (73%) and Beijing (27%)
superfamilies [21]. Therefore, based on previous and
present reports, it is clear that both Haarlem I and Beijing
strains can cause epidemic and from epidemiological
point it is necessary to conduct more extensive surveil-
lance of MDR-TB strains because they might cause serious
outbreaks [12]. During the year 2000–2005, 32% of ini-
tial TB patients that referred to our unit were from Afghan
born immigrants [20]. Majority of these patients (58%)
had either resistant to any drug or drug combination
including MDR-TB [20]. In present report also, the rate of
resistance to any drug or drug combination in Afghan
patients were more than two folds as compared to Iranian
(table 1). These finding highlighted the need to reinforce
the TB policy measures with regards to screening immi-
grants from neighboring countries, which is absent in the
current system. Based on IS6110-RFLP, 74.8% of patients
were grouped in non- cluster cases and it was assumed
that reactivation of endogenous infection remains the
more probable cause of active tuberculosis, in studied
populations (table. 1). Today, it is known that steriliza-
tion of a pulmonary lesion is possible through effective
treatment regimens. But, it is also accepted that subse-
quent episodes of TB are almost invariably caused by
endogenous reactivation of resistant strains [7,24]. In
other words, majority of those who returned for treatment
after default might develop resistant in comparison to
those who returned after exogenous reinfection [7,9,25].
In this regards, we also found high number of MDR-TB
strains among endogenous reactivation cases. The fre-
quent superfamilies in MDR-TB cases of non-cluster cases
were CASI (19; 31%) and EAI3 (12; 20%) (table. 2). Based
on Sreevatsan et al, the EAI and CAS are belong to genetic
group I organisms which are evolutionary older and they
are the most frequent superfamilies in Central Asia and
Middle East [26]. Our results also showed different sus-
ceptibility patterns for isolates in same clusters e.g., in the
cluster numbered-27 (figure. 1); one strain was suscepti-
ble to all drugs tested and the other two strains were resist-
ant to isoniazid. Mitchison [27] has already described the
emergence of such drug resistance strains, solely due to
irregularity in administration of drugs. That means the
strains became acquired drug resistance isolates, as classi-
cally defined [24,25]. In the studied population, no rela-
tion was found between the patterns of IS6110-RFLP and
susceptibility results. In fact, the number and manner of
IS6110 positioning along the genome of M. tuberculosis
does not have any relation with drug-susceptibility results
[2,4]. Last but not the least, the major consideration of the
usefulness of the IS6110-RFLP typing method is its specif-
icity, which depends on the number of bands obtained. In
the present study, 12% of collected strains had low copies
of IS6110. Previously, we detected only 5.4% of strains
with low IS6110 copy number [20]. Thereby, the preva-
lence of M. tuberculosis isolates with low or no IS6110
insert is not clear and further studies are required to show
the real distribution of these strains within the country.
Conclusion
Previous studies showed that more than 90% of active
cases of tuberculosis in Iran resulted from reactivation of
infection-contracted years before, and that recently trans-
mitted diseases had a minor role. In this study, we also
showed the higher rate of reactivation (74.8%) versus
recent transmission (25.2%). Although, the incidence of
intra- community transmission had a significant rises
from 13% in 2005 to 41% in 2007. Therefore, it is neces-
sary to adapt new strategies for rapid diagnosis, and effi-
cient treatment of TB patients.
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